Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals

Schizophrenia Research

Volumn 108, Issue 1-3, 2009, Pages 85-92

  Sun, Daqiang ^a,b   Phillips, Lisa ^a   Velakoulis, Dennis ^a   Yung, Alison ^a   McGorry, Patrick D ^a   Wood, Stephen J ^a   van Erp, Theo G M ^b   Thompson, Paul M ^c   Toga, Arthur W ^c   Cannon, Tyrone D ^b   Pantelis, Christos ^a,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Brain mapping; Longitudinal; MRI; Prodrome; Schizophrenia; Ultra high risk

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN CORTEX; BRAIN MAPPING; BRAIN SIZE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LONGITUDINAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA;

ADOLESCENT; ADULT; BRAIN MAPPING; CEREBRAL CORTEX; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PERSONALITY INVENTORY; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS; RISK; YOUNG ADULT;

EID: 60249087534     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.11.026     Document Type: Article

References (38)

1. Brewer W.J., Wood S.J., Phillips L.J., Francey S.M., Pantelis C., Yung A.R., Cornblatt B., and McGorry P.D. Generalised and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr. Bull. 32 3 (2006) 538-555
2. Cannon T.D., Hennah W., van Erp T.G., Thompson P.M., Lonnqvist J., Huttunen M., Gasperoni T., Tuulio-Henriksson A., Pirkola T., Toga A.W., Kaprio J., Mazziotta J., and Peltonen L. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch. Gen. Psychiatry 62 11 (2005) 1205-1213
3. Cannon T.D., Thompson P.M., van Erp T.G., Toga A.W., Poutanen V.P., Huttunen M., Lonnqvist J., Standerskjold-Nordenstam C.G., Narr K.L., Khaledy M., Zoumalan C.I., Dail R., and Kaprio J. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 99 5 (2002) 3228-3233
4. Cannon T.D., van Erp T.G., Bearden C.E., Loewy R., Thompson P., Toga A.W., Huttunen M.O., Keshavan M.S., Seidman L.J., and Tsuang M.T. Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr. Bull. 29 4 (2003) 653-669
5. Craddock N., O'Donovan M.C., and Owen M.J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr. Bull. 32 1 (2006) 9-16
6. Dorph-Petersen K.A., Pierri J.N., Perel J.M., Sun Z., Sampson A.R., and Lewis D.A. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30 9 (2005) 1649-1661
7. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., and Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 12 (2001) 6917-6922
8. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. J. Psychiatr. Res. 17 (1982) 319-334
9. Garner B., Pariante C.M., Wood S.J., Velakoulis D., Phillips L., Soulsby B., Brewer W.J., Smith D.J., Dazzan P., Berger G.E., Yung A.R., van den Buuse M., Murray R., McGorry P.D., and Pantelis C. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol. Psychiatry 58 5 (2005) 417-423
10. Glantz L.A., and Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57 1 (2000) 65-73
11. Ho B.C., Andreasen N.C., Nopoulos P., Arndt S., Magnotta V., and Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch. Gen. Psychiatry 60 6 (2003) 585-594
12. Job D.E., Whalley H.C., Johnstone E.C., and Lawrie S.M. Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage 25 4 (2005) 1023-1030
13. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., Kahn R.S., Keefe R.S., Green A.I., Gur R.E., McEvoy J., Perkins D., Hamer R.M., Gu H., and Tohen M. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry 62 4 (2005) 361-370
14. MacDonald J.D., Kabani N., Avis D., and Evans A.C. Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI. Neuroimage 12 3 (2000) 340-356
15. Mathalon D.H., Rapoport J.L., Davis K.L., and Krystal J.H. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry. Arch. Gen. Psychiatry 60 (2003) 846-848
16. Mazziotta J.C., Toga A.W., Evans A., Fox P., and Lancaster J. A probabilistic atlas of the human brain: theory and rationale for its development The International Consortium for Brain Mapping, (ICBM). Neuroimage 2 2 (1995) 89-101
17. Nakamura M., Salisbury D.F., Hirayasu Y., Bouix S., Pohl K.M., Yoshida T., Koo M.S., Shenton M.E., and McCarley R.W. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol. Psychiatry 62 7 (2007) 773-783
18. Pakkenberg B. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors. Biol. Psychiatry 34 11 (1993) 768-772
19. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., Yung A.R., Bullmore E.T., Brewer W., Soulsby B., Desmond P., and McGuire P.K. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361 9354 (2003) 281-288
20. Pantelis C., Yucel M., Wood S.J., McGorry P.D., and Velakoulis D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust. N. Z. J. Psychiatry 37 4 (2003) 399-406
21. Pantelis C., Yucel M., Wood S.J., Velakoulis D., Sun D., Berger G., Stuart G.W., Yung A., Phillips L., and McGorry P.D. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr. Bull. 31 3 (2005) 672-696
22. Pantelis C., Velakoulis D., Wood S.J., Yucel M., Yung A.R., Phillips L.J., Sun D.Q., and McGorry P.D. Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int. Rev. Psychiatry 19 4 (2007) 371-381
23. Phillips L.J., McGorry P.D., Garner B., Thompson K.N., Pantelis C., Wood S.J., and Berger G. Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. Aust. N. Z. J. Psychiatry 40 9 (2006) 725-741
24. Porteous D.J., Thomson P., Brandon N.J., and Millar J.K. The genetics and biology of DISC1-an emerging role in psychosis and cognition. Biol. Psychiatry 60 (2006) 123-131
25. Salisbury D.F., Kuroki N., Kasai K., Shenton M.E., and McCarley R.W. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch. Gen. Psychiatry 64 5 (2007) 521-529
26. Selemon L.D., Rajkowska G., and Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry 52 10 (1995) 805-818 discussion 819-820
27. Selemon L.D., Lidow M.S., and Goldman-Rakic P.S. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biol. Psychiatry 46 2 (1999) 161-172
28. Shenton M.E., Dickey C.C., Frumin M., and McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 49 1-2 (2001) 1-52
29. Sowell E.R., Thompson P.M., Tessner K.D., and Toga A.W. Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: inverse relationships during postadolescent brain maturation. J. Neurosci. 21 22 (2001) 8819-8829
30. Strakowski S.M., Delbello M.P., and Adler C.M. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol. Psychiatry 10 1 (2005) 105-116
31. Sun D., Stuart G.W., Jenkinson M., Wood S.J., McGorry P.D., Velakoulis D., van Erp T.G., Thompson P.M., Toga A.W., Smith D.J., Cannon T.D., and Pantelis C. Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol. Psychiatry (2008) 10.1038/mp.2008.34 advance online publication 8 July
32. Thompson P.M., Hayashi K.M., Sowell E.R., Gogtay N., Giedd J.N., Rapoport J.L., de Zubicaray G.I., Janke A.L., Rose S.E., Semple J., Doddrell D.M., Wang Y., van Erp T.G., Cannon T.D., and Toga A.W. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage 23 Suppl 1 (2004) S2-18
33. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., Starkey M., Webster M.J., Yolken R.H., and Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362 9386 (2003) 798-805
34. van Haren N.E., Hulshoff Pol H.E., Schnack H.G., Cahn W., Mandl R.C., Collins D.L., Evans A.C., and Kahn R.S. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology 32 10 (2007) 2057-2066
35. Weinberger D.R., and McClure R.K. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?. Arch. Gen. Psychiatry 59 6 (2002) 553-558
36. Woods B.T. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am. J. Psychiatry 155 12 (1998) 1661-1670
37. Yung A., Phillips L., and McGorry P.D. Treating Schizophrenia in the Prodromal Phase (2004), Taylor & Francis, London
38. Yung A.R., Phillips L.J., Yuen H.P., Francey S.M., McFarlane C.A., Hallgren M., and McGorry P.D. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr. Res. 60 1 (2003) 21-32